Investigational Drug Information for Satavaptan
✉ Email this page to a colleague
What is the drug development status for Satavaptan?
Satavaptan is an investigational drug.
There have been 10 clinical trials for Satavaptan.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2006.
The most common disease conditions in clinical trials are Ascites, Liver Cirrhosis, and Hyponatremia. The leading clinical trial sponsors are Sanofi and [disabled in preview].
Summary for Satavaptan
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 29 |
| WIPO Patent Applications | 8 |
| Japanese Patent Applications | 13 |
| Clinical Trial Progress | Phase 3 (2006-07-01) |
| Vendors | 20 |
Recent Clinical Trials for Satavaptan
| Title | Sponsor | Phase |
|---|---|---|
| A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia | Sanofi | Phase 3 |
| Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver | Sanofi | Phase 3 |
| Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) | Sanofi | Phase 3 |
Clinical Trial Summary for Satavaptan
Top disease conditions for Satavaptan
Top clinical trial sponsors for Satavaptan
US Patents for Satavaptan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
